In-vitro/In-vivo comparison of leuprolide acetate release from an in-situ forming plga system

DARU, Journal of Pharmaceutical Sciences

Volumn 21, Issue 1, 2013, Pages

  Mashayekhi, Roya ^a,b   Mobedi, Hamid ^b   Najafi, Jamal ^c   Enayati, Marjan ^d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b IRAN POLYMER AND PETROCHEMICAL INSTITUTE   (Iran)

^c Center of Veterinary   (Iran)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Biodegradable polymer; Drug delivery system; In vitro; In vivo; Poly (lactide co glycolide) (PLGA); Rat

Indexed keywords

LEUPRORELIN; POLYGLACTIN; RESOMER; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFUSION; DRUG FORMULATION; DRUG RELEASE; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRESSURE; RAT; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; ULTRAVIOLET SPECTROPHOTOMETRY; ULTRAVIOLET SPECTROSCOPY;

EID: 84881425704     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-21-57     Document Type: Article

References (20)

1. Biocompatibility of an Injectable in-situ Forming Depot for Peptide Delivery. Hammer KS, Boisclair J, Schuetz H, Petersen H, Goepferich A, Pharm. Sci 2010 99 4390 4399 10.1002/jps.22149
2. Smart Polymers for Controlled Delivery of Proteins and Peptides. Fogueri LR, Singh S, A Review of Patents 2009 3 7 40 48
3. Myotoxicity studies of injectable biodegradable in-situ forming drug delivery system. Kranz H, Brazeau GA, Napaporn J, Martin RL, Millard W, Bodmeier R, Int J Pharm 2001 212 11 10.1016/S0378-5173(00)00568-8 11165816 (Pubitemid 32121946)
4. Stability of poly (D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems. Bodmeier S, López Esguerra V, Körber M, Dong WY, J.C.R 2006 115 2 158 167 10.1016/j.jconrel.2006.07.013 (Pubitemid 44537494)
5. Polymeric delivery formulations of Leuprolide with improved efficacy. Dunn RL, Garrett JS, Ravivarapu H, Chandrashekar BL, US Patent 2004 6 773,714
6. Persistent Suppression of the Pituitary-Gonadal System in Female Rats by Three-Month Depot Injectable Microspheres of Leuprorelin Acetate. Okada H, Doken Y, Ogawa Y, J Pharm Sci 1996 85 10 1045
7. Incidence of bone fracture in patients receiving luteinizing hormone-releasing hormone agonists for prostate cancer. Hatano T, BJU Int 2000 86 449 452 10.1046/j.1464-410X.2000.00774.x 10971270
8. leuprolide acetate in a novel sustained-release delivery system. Eligard SO, Urology 2003 61 2Suppl 1 25 31 12667884
9. Inter A, prolonged release parenteral drug delivery system. Bari H, Inter. J Pharm. Sci. Rev. Res 2010 3 1 1 11
10. Effect of Additives on Release Profile of Leuprolide Acetate in an In-situ Forming Controlled-Release System: In-vitro Study. Zare M, Mobedi H, Barzin J, Mivehchi H, Jamshidi A, Mashayekhi R, J. Appl. Poly. Sci 2008 107 3781 3787 10.1002/app.27520 (Pubitemid 351388247)
11. Allcock HR. Krogman NR, Singh A, Nair LS, Laurencin CT, Biomacromolecules 2007 8 13106 13125
12. Polymeric delivery formulations of leuprolide with improved efficacy. Dunn RL, Garrett JS, Ravivarapu H, Chandrashekar B, US Patent 2003 656 5874
13. Solubilizing excipients in oral and injectable formulations. Strickley RG, Pharm Res 2001 21 201 230
14. Pharmacokinetics of once-month injectable microspheres of leuprolide acetate. Okada H, Inoue Y, Heya T, Ueno H, Ogawa Y, Toguchi H, Pharm Res 1991 8 6 787 791 10.1023/A:1015818504906 1905810
15. Validation of analytical procedures: Methodology. Guideline, I.C.H.H.T, ICH 1996
16. Influence of the poly (lactide-co-glycolide) type on the Leuprolide release from in-situ forming microparticle systems. Luan X, Bodmeier R, J.C.R 2006 110 266 272 10.1016/j.jconrel.2005.10.005 (Pubitemid 41827479)
17. The effect of additives on naltrexone hydrochloride release and solvent removal rate from an injectable in-situ forming PLGA implant. Bakhshi R, Vasheghani-Farahani E, Mobedi H, Jamshidi A, Khakpour M, Poly. Adv. Tech 2006 17 354 359 10.1002/pat.717 (Pubitemid 44044486)
18. Modification of the tri-phasic release pattern of Leuprolide Acetate-loaded poly (lactide-co-glycolide) microparticles. Luan X, Bodmeier R, Euro. J. Pharm. Biopharm 2006 63 205 214 10.1016/j.ejpb.2005.12.010 (Pubitemid 43776217)
19. Controlled release of nerve growth factor from sandwiched poly (D, L-lactide-co-glycolide) films for the application in neural tissue engineering. Khang G, Kyuang JE, Rhee JM, Macromol Res 2003 11 5 334 340 10.1007/BF03218373 (Pubitemid 37414403)
20. Formulation of an injectable implant for peptide delivery and mechanistic study of the effect of polymer molecular weight on its release behavior. Astaneh R, Moghimi HR, Erfan M, Mobedi H, DARU 2006 14 2 65 70 (Pubitemid 43971917)